Novel dual BET and PLK1 inhibitor WNY0824 exerts potent...

  • Main
  • 2020 / 03
  • Novel dual BET and PLK1 inhibitor WNY0824 exerts potent...

Novel dual BET and PLK1 inhibitor WNY0824 exerts potent anti-tumor effects in CRPC by inhibiting transcription factor function and inducing mitotic abnormality

Xu, Ying, Wang, Qianqian, Xiao, Kunjie, Liu, Zhihao, Zhao, Lifeng, Song, Xuejiao, Hu, Xi, Feng, Zhanzhan, Gao, Tiantao, Zuo, Weiqiong, Zeng, Jun, Wang, Ningyu, Yu, Luoting
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.mct-19-0578
Date:
March, 2020
File:
PDF, 14.62 MB
2020
Conversion to is in progress
Conversion to is failed